These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22774994)

  • 1. Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects.
    Huurman VA; van der Torren CR; Gillard P; Hilbrands R; van der Meer-Prins EP; Duinkerken G; Gorus FK; Claas FH; Keymeulen B; Roelen DL; Pipeleers DG; Roep BO
    Clin Exp Immunol; 2012 Aug; 169(2):190-8. PubMed ID: 22774994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.
    Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH
    Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation.
    Huurman VA; Hilbrands R; Pinkse GG; Gillard P; Duinkerken G; van de Linde P; van der Meer-Prins PM; Versteeg-van der Voort Maarschalk MF; Verbeeck K; Alizadeh BZ; Mathieu C; Gorus FK; Roelen DL; Claas FH; Keymeulen B; Pipeleers DG; Roep BO
    PLoS One; 2008 Jun; 3(6):e2435. PubMed ID: 18560516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients.
    van Kampen CA; van de Linde P; Duinkerken G; van Schip JJ; Roelen DL; Keymeulen B; Pipeleers DG; Claas FH; Roep BO
    Transplantation; 2005 Jul; 80(1):118-26. PubMed ID: 16003242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allograft-specific cytokine profiles associate with clinical outcome after islet cell transplantation.
    Huurman VA; Velthuis JH; Hilbrands R; Tree TI; Gillard P; van der Meer-Prins PM; Duinkerken G; Pinkse GG; Keymeulen B; Roelen DL; Claas FH; Pipeleers DG; Roep BO
    Am J Transplant; 2009 Feb; 9(2):382-8. PubMed ID: 19067657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients.
    Roep BO; Stobbe I; Duinkerken G; van Rood JJ; Lernmark A; Keymeulen B; Pipeleers D; Claas FH; de Vries RR
    Diabetes; 1999 Mar; 48(3):484-90. PubMed ID: 10078547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hair follicle dermal sheath derived cells improve islet allograft survival without systemic immunosuppression.
    Wang X; Hao J; Leung G; Breitkopf T; Wang E; Kwong N; Akhoundsadegh N; Warnock GL; Shapiro J; McElwee KJ
    J Immunol Res; 2015; 2015():607328. PubMed ID: 26000314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
    Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
    Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived beta-cell cytotoxic CD8+ T-cell clones in vivo.
    Utsugi T; Yoon JW; Park BJ; Imamura M; Averill N; Kawazu S; Santamaria P
    Diabetes; 1996 Aug; 45(8):1121-31. PubMed ID: 8690161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts.
    Jaeger C; Brendel MD; Hering BJ; Eckhard M; Bretzel RG
    Diabetes; 1997 Nov; 46(11):1907-10. PubMed ID: 9356046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamic acid decarboxylase antibodies are more frequent than islet cell antibodies in islet transplanted IDDM patients and persist or occur despite immunosuppression.
    Jaeger C; Hering BJ; Hatziagelaki E; Federlin K; Bretzel RG
    J Mol Med (Berl); 1999 Jan; 77(1):45-8. PubMed ID: 9930926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microencapsulated adult porcine islets transplanted intraperitoneally in streptozotocin-diabetic non-human primates.
    Safley SA; Kenyon NS; Berman DM; Barber GF; Willman M; Duncanson S; Iwakoshi N; Holdcraft R; Gazda L; Thompson P; Badell IR; Sambanis A; Ricordi C; Weber CJ
    Xenotransplantation; 2018 Nov; 25(6):e12450. PubMed ID: 30117193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of pig islet xenograft survival in rats immunosuppressed with FK506.
    Tze WJ; Tai J; Cheung SS
    Diabetes Res Clin Pract; 1997 Sep; 37(3):149-56. PubMed ID: 9306035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low energy X-ray (grenz ray) treatment of purified islets prior to allotransplant markedly decreases passenger leukocyte populations.
    Pawlick R; Gala-Lopez B; Pepper AR; Abualhassan N; Bruni A; Suzuki K; Rayat G; Elliott JF; Shapiro AMJ
    Islets; 2017 Jul; 9(4):e1330742. PubMed ID: 28692319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade.
    Bühler L; Deng S; O'Neil J; Kitamura H; Koulmanda M; Baldi A; Rahier J; Alwayn IP; Appel JZ; Awwad M; Sachs DH; Weir G; Squifflet JP; Cooper DK; Morel P
    Xenotransplantation; 2002 Jan; 9(1):3-13. PubMed ID: 12005102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance.
    Wang XY; Sun J; Wang C; France M; Sheil AG
    Transplantation; 2001 Jan; 71(1):102-11. PubMed ID: 11211174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL22 Prevents Rejection of Mouse Islet Allografts and Induces Donor-Specific Tolerance.
    Montane J; Obach M; Alvarez S; Bischoff L; Dai DL; Soukhatcheva G; Priatel JJ; Hardenberg G; Levings MK; Tan R; Orban PC; Verchere CB
    Cell Transplant; 2015; 24(10):2143-54. PubMed ID: 26423995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloantigen gene transfer to hepatocytes promotes tolerance to pancreatic islet graft by inducing CD8
    Le Guen V; Judor JP; Boeffard F; Gauttier V; Ferry N; Soulillou JP; Brouard S; Conchon S
    J Hepatol; 2017 Apr; 66(4):765-777. PubMed ID: 27914923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.